AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesTechnology, Industry, AgricultureInformation ScienceHealth Care
Compression BandagesBandagesStockings, CompressionVaricose UlcerBromcresol GreenPressureBandages, HydrocolloidGalanthusData CompressionSpinal Cord CompressionNerve Compression SyndromesFractures, CompressionIntermittent Pneumatic Compression DevicesCasts, SurgicalSprains and StrainsBracesWound HealingCompressive StrengthHeart MassageTransducers, PressureSplintsAnemia, Iron-DeficiencyCyanoacrylatesGaggingAnkle InjuriesHemostatic TechniquesEntropionEquipment DesignTreatment OutcomeLegVenous InsufficiencyAmputation StumpsElasticityVaricose VeinsChitosan

Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. (1/31)

 (+info)

Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial. (2/31)

 (+info)

Multicenter randomized trial comparing compression with elastic stocking versus bandage after surgery for varicose veins. (3/31)

 (+info)

Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial. (4/31)

BACKGROUND: Classic wound drainage is still common in hip replacement but its benefit is doubtful. The role of systemic administration of proteinase inhibitors like aprotinin to avoid perioperative blood loss is still unclear. PATIENTS AND METHODS: In a prospective randomized trial, the perioperative blood loss in alloplastic hip replacement under the influence of proteinase inhibitor (aprotinin, Trasylol(R)) using wound drainage as well as compression treatment alone were compared. 80 patients were prospectively randomized in 4 arms. Patients received either aprotinin or placebo during surgery as well as drainage or targeted external wound compression. RESULTS: Observing the "drug therapy" aprotinin had no effect on the intra- or postoperative blood loss (p>0.05), a trend to lower postoperative hemoglobin decline was found, but without significance. Thrombosis occurred in neither the aprotinin nor in the placebo group. Two patients had a severe allergic drug reaction and were excluded from the study. Under "non drug therapy" with compression therapy and wound drainage a significant difference in blood loss was found (p<0.001). The blood loss was higher under the wound drainage. There was no influence on the infection rate. Yet we could observe increased bruising under the sole external compression treatment. CONCLUSION: The administration of aprotinin did not achieve the desired reduction of perioperative blood loss. Hence, costs and two severe allergic drug reactions in our study represent arguments against its use in regular treatment. Furthermore, it seems that wound drainage is neglectable in hip replacement and can be substituted by a sole compression treatment.  (+info)

Conservative and dietary interventions for cancer-related lymphedema: a systematic review and meta-analysis. (5/31)

 (+info)

Effect of elastic bandaging and prosthesis on the decrease in stump volume. (6/31)

 (+info)

Compression leggings modestly affect cardiovascular but not cerebrovascular responses to heat and orthostatic stress in young and older adults. (7/31)

 (+info)

The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. (8/31)

 (+info)